Thomas Hallam Net Worth & Insider Trades
Thomas Hallam - Chief Executive Officer, Palisade Bio, Inc
What is Thomas Hallam's Net Worth?
The current estimated net worth of Palisade Bio, Inc's Chief Executive Officer, Thomas Hallam, is estimated to be about $3.53K . Thomas Hallam owns about 57,592 units of Palisade Bio, Inc common stock. In the last year at Palisade Bio, Inc, Thomas Hallam has sold an estimated value of $0 worth.
What is Thomas Hallam's Past Insider Trading?
Thomas Hallam's largest purchase order was 6,000 units , worth over $14.94K on September 22, 2021. In total, Thomas Hallam has made about 6 transactions over a year of their time at Palisade Bio, Inc. Thomas Hallam usually trades in February, with the busiest year in 2022. The most recent transaction was a purchase order of 40,000 units , worth over $10K on August 18, 2022.
Thomas Hallam
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Thomas Hallam's' Mailing Address?
- Mailing address is C/o Seneca Biopharma, Inc. 20271 Goldenrod Lane Germantown MD 20876 MD
Palisade Bio, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|---|
| Kenneth Carter, PhD, | 2019 | $395,000 | $20,000 | - | $425,409 | - | - | - | $840,409 |
| Kenneth Carter, PhD, | 2018 | - | - | - | - | - | - | - | - |
| Richard J. Daly, | 2019 | - | - | - | - | - | - | - | - |
| Richard J. Daly, | 2018 | $239,167 | $146,370 | - | - | - | - | - | $385,537 |
| James Scully, | 2019 | - | - | - | - | - | - | - | - |
| James Scully, | 2018 | $208,725 | - | - | $191,310 | - | - | - | $400,035 |
| Matthew Kalnik, PhD | 2019 | - | - | - | - | - | - | $358,758 | $358,758 |
| Matthew Kalnik, PhD | 2018 | - | - | - | - | - | - | - | - |
| Dane Saglio | 2019 | - | - | - | - | - | - | $84,750 | $84,750 |
| Dane Saglio | 2018 | - | - | - | - | - | - | - | - |
| No matching records found | |||||||||
Source: https://www.sec.gov/Archives/edgar/data/1357459/000117184320004540/def14a_062320.htm
What are Palisade Bio, Inc's Past Insider Trades?
Palisade Bio, Inc's most recent insider trade came on September 2, 2022 by JD Finley who bought 19,481 units worth $2.8K . In the last year, insiders at Palisade Bio, Inc have sold an estimated value of $1.41K and bought an estimated value of $164.63K worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are JD Finley, CEO, Thomas Hallam, Chief Executive Officer, and Michael Dawson, Chief Medical Officer .
PALISADE BIO, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||